Green Cross Vaccine to construct new high tech vaccine plant.

Green Cross Vaccine's new plant has been completed at Shingal, Gyeonggido on May 17 for the production of B hepatitis viral vaccine and pediatric combined vaccines with a double time of its production capacity (400 vials/min.), about 100 million dose per year, than the current vaccine production.

Green Cross Vaccine is a subsidiary of Berna Biotech company, a Swiss vaccine production compa...